Soft tissue surgical robot developers muscling into the fast-growing field gained more momentum heading into the fourth quarter as they chase longtime market leader Intuitive Surgical.
Among those advancing are Medtronic, which in September announced a doubling in the size of its London hub for AI and robotics and reported positive results from a study of its Hugo system in hernia repair. This month, the medtech giant said it began its third U.S. investigational device exemption study for Hugo, in gynecology.
Medtronic expects the robot to make its U.S. market debut with an initial indication in urology later in its fiscal year, which ends in April 2026.
SS Innovations International took steps to speed a U.S. market entry, switching its focus to a 510(k) submission from the de novo application it previously considered, as well as hiring a new CFO to support its global expansion.
Intuitive, for its part, unveiled new software updates with FDA clearances, including a replay feature for its da Vinci system that allows surgeons to review parts of a procedure while it is still underway.
MedTech Dive is following the top developments in surgical robotics. Catch up on the latest in this roundup of our coverage:
